InsiderTrades.com logo
Nadja West net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Nadja West Biography and Net Worth

Director of Tempus AI

Nadja West, M.D. has served as a member of our board of directors since April 2021. Dr. West has also served on the boards of directors of several other public companies, including serving as a member of the board of directors of Johnson & Johnson since December 2020, Tenet Healthcare Corp since October 2019, and Nucor Corporation since September 2019. From December 2015 to October 2019, Dr. West served as the 44th Surgeon General of the U.S. Army, and the Commanding General of the U.S. Army Medical Command. Dr. West currently serves as Trustee of both the National Recreation Foundation and Mount St. Mary’s University, and board member of Americares and The Woodruff Foundation. She was recently appointed an independent member of the NCAA Board of Governors. Dr. West holds a B.S. from the United States Military Academy at 185 West Point, an M.D. from the George Washington University School of Medicine, and an M.S. from National War College.

What is Nadja West's net worth?

The estimated net worth of Nadja West is at least $1.59 million as of March 4th, 2025. West owns 37,705 shares of Tempus AI stock worth more than $1,588,135 as of April 13th. This net worth approximation does not reflect any other assets that West may own. Learn More about Nadja West's net worth.

How do I contact Nadja West?

The corporate mailing address for West and other Tempus AI executives is 600 WEST CHICAGO AVENUE SUITE 510, CHICAGO IL, 60654. Tempus AI can also be reached via phone at 800-976-5448 and via email at investorrelations@tempus.com. Learn More on Nadja West's contact information.

Has Nadja West been buying or selling shares of Tempus AI?

Nadja West has not been actively trading shares of Tempus AI over the course of the past ninety days. Most recently, Nadja West sold 809 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a transaction totalling $41,347.99. Following the completion of the sale, the director now directly owns 37,705 shares of the company's stock, valued at $1,927,102.55. Learn More on Nadja West's trading history.

Who are Tempus AI's active insiders?

Tempus AI's insider roster includes Jennifer Doudna (Director), David Epstein (Director), Ryan Fukushima (COO), Eric Lefkofsky (Founder & CEO), Erik Phelps (EVP and Chief Administrative and Legal Officer), Andrew Polovin (General Counsel), James Rogers (CFO), and Nadja West (Director). Learn More on Tempus AI's active insiders.

Are insiders buying or selling shares of Tempus AI?

In the last year, insiders at the sold shares 42 times. They sold a total of 6,447,010 shares worth more than $352,456,255.54. The most recent insider tranaction occured on March, 31st when Director Wayne A.I. Frederick sold 3,000 shares worth more than $136,620.00. Learn More about insider trades at Tempus AI.

Information on this page was last updated on 3/31/2025.

Nadja West Insider Trading History at Tempus AI

See Full Table

Nadja West Buying and Selling Activity at Tempus AI

This chart shows Nadja West's buying and selling at Tempus AI by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40k-$20k$0$20k$40kTotal Insider BuyingTotal Insider Selling

Tempus AI Company Overview

Tempus AI logo
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Read More

Today's Range

Now: $42.12
Low: $38.79
High: $42.35

50 Day Range

MA: $56.19
Low: $37.23
High: $89.44

2 Week Range

Now: $42.12
Low: $22.89
High: $91.45

Volume

8,540,487 shs

Average Volume

5,511,880 shs

Market Capitalization

$7.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A